Gronghui September 20 | Hongyuan Pharmaceutical Co., Ltd. (301246.SZ) fell nearly 5%, and its share price fell to 30 yuan, with a new low listing price of 28.50 yuan, with a total market capitalization of 11.5 billion yuan. On the news, the company today lifted the ban on the listing of 2.8855 million restricted shares, placing shares for the company's IPO, accounting for 0.72% of the company's total share capital. In addition, the recent popularity of weight-loss drugs, the company recently said that the company owns "a weight-loss function composition and preparation method" invention patent has not yet been converted.
A股异动丨宏源药业跌近5%创新低 股份解禁
Changes in A-shares 丨 Hongyuan Pharmaceutical fell nearly 5% to reach a record low and the ban on shares was lifted
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.